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Professionals and amateurs
Professional antigen-presenting cells, notably dendritic cells, play
a key role in stimulating naive T cells - but nonprofessional antigen-
presenting cells, such as fibroblasts, may also contribute to this process.
Stimulation of mature T cells generally requires the
presence of specialized antigen-presenting cells, such as
macrophages and dendritic cells [1-6]. These cells are
strategically positioned in the T-cell-dependent areas of
lymphoid tissues and express high levels of the costimula-
tory molecules required for optimal signaling by T cells.
Despite the importance of specialized antigen-presenting
cells, Kundig et al. [7] have recently reported that primary
cytotoxic T lymphocyte (CTL) responses to viral antigens
in vivo can be initiated by fibroblasts transfected with viral
proteins. In view of this finding, the requirements for
activating unprimed T cells need to be re-evaluated.
Functions of antigen-presenting cells
To present antigen to T cells, antigen-presenting cells first
degrade native proteins into peptides and then load these
peptides onto MHC molecules - class I MHC molecules
for T cells expressing CD8 and class II molecules for
CD4-bearing cells [5,8]. Peptide loading occurs predomi-
nantly in the endoplasmic reticulum for class I molecules
and in endosomes for class II molecules. When displayed
on the cell surface, peptide-bound MHC molecules on
antigen-presenting cells are recognized by T cells via anti-
gen-specific cx3d T-cell receptors. In the case of activated T
cells, this recognition signals the T cells to manifest their
effector function. For example, a pre-activated, virus-spe-
cific CD8+ CTL encountering class I-peptide complexes
on virus-infected epithelial cells in the lung will be sig-
nalled to destroy the epithelial cells and thus promote
clearance of the virus.
The situation with naive resting T cells is different. For
these cells, signalling via the T-cell receptor (signal 1) is
generally nonimnunogenic unless accompanied by
'second signals' resulting from contact with costinmulatory
molecules [4]. Specialized antigen-presenting cells express
a spectrum of costimulatory molecules, such as B7, and
these molecules interact with complementary molecules
on T cells, such as CD28 or CTLA4 [3,4,6]. Although the
signalling pathways initiated by T-cell-receptor-peptide-
MHC and CD28-B7 interactions seem to be partly over-
lapping, the prevailing view is that the CD28-B7 inter-
action is crucial for the production of growth-promoting
cytokines such as interleukin-2 (IL-2). Thus, blocking a
T cell from contact with B7 using soluble CTLA4-
immunoglobulin fusion protein (expressed from recombi-
nant DNA constructs) generally causes a marked inhibi-
tion of the primary response, both in vitro and in vivo.
Costimulation is not unique to the CD28-B7 interaction,
however, and there is increasing evidence that a spectrum
of molecules on antigen-presenting cells - such as
intercellular adhesion molecule 1 (ICAM-1) and heat
stable antigen (HSA) - can deliver costimulatory signals
to T cells [9,10].
Although many different cell types express at least low
levels of costimulatory molecules, high levels of expression
of these molecules is largely restricted to professional anti-
gen-presenting cells, especially dendritic cells [3]. These
cells are scattered throughout the body, but are concen-
trated in the T-cell-dependent areas of the lymphoid tis-
sues - the periarteriolar sheaths of the splenic white pulp
and the paracortex of lymph nodes. Dendritic cells are
thus ideally positioned to present antigen to naive T cells.
Cell types that have antigen-presenting function in vitro
Dendritic cells have potent antigen-presenting function in
vitro, and some workers argue that stimulation of
unprimed T cells is under the sole control of dendritic
cells [3]. Much of the evidence on the antigen-presenting
function of dendritic cells has come from studies on the
response of naive T cells to cells expressing foreign MHC
molecules (alloantigens). Here, there is general agreement
that small numbers of dendritic cells are highly efficient at
stimulating primary mixed lymphocyte reactions by
unprimed T cells in the absence of added lymphokines
[2,3]. Whether or not other cell types can stimulate such
reactions has long been controversial. Some workers
report that, unlike dendritic cells, macrophages and B cells
have little or no capacity to stimulate naive T cells [3].
However, in the case of CD8+ T cells, others have
reported that primary mixed lymphocyte reactions to class
I alloantigens can be elicited by a spectrum of cell types,
including activated macrophages, T blast cells, transformed
fibroblasts and mastocytoma (P815) cells [2]; there are also
reports that reactions can be stimulated by vascular
endothelial cells [11]. The antigen-presenting function of
resting T and B cells is generally very low, but when lym-
phoid cells are activated and/or treated with neura-
minidase, which reduces the net surface charge, antigen-
presenting function is increased dramatically [2,12].
Indeed, after neuraminidase treatment, their function in
presenting antigen to activated CD8+ cells is almost as
potent as that of dendritic cells [2].
Although some of the cell types discussed above lack the
costimulatory molecule B7, virtually all cell types express
at least low levels of molecules that have costimulatory
function. Hence, the data described above do not chal-
lenge the view that T-cell activation requires costimula-
tion. However, the data do suggest that the two-signal
model for T-cell activation may be oversimplistic. This
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writer favors a holistic model, in which T-cell activation
leading to cytokine production and proliferation reflects
the overall avidity of the interaction between T cells and
antigen-presenting cells [2,13]. The avidity of T-
cell-antigen-presenting cell interaction is presumably a
reflection of many different factors, including the density
of antigen (peptide-MHC complexes) on the antigen-
presenting cell, the relative affinity of the T-cell receptor
for antigen, the range of costimulatory molecules on the
antigen-presenting cell and the net surface charge of these
cells (see Fig. 1).
According to this model, high-avidity interaction
promotes strong crosslinking of T-cell receptor-CD3
complexes on the T-cell surface, which in turn leads to
strong signalling via various interconnected pathways
within the T cell; costimulation feeds into this network
and serves to boost the T-cell receptor-CD3 signal.
High-intensity signalling within T cells stimulates pro-
duction of cytokines (such as IL-2) and of the receptors
for these cytokines (such as the IL-2 receptor). The T
cells then proliferate and differentiate into effector cells.
When the intensity of signalling is below a certain
threshold - for example, when the density of antigen or
the level of costimulation is low - the responding T
cells express IL-2 receptors but not IL-2. Hence, the T
cells fail to proliferate unless exposed to exogenous IL-2.
This scenario is based on studies with CD8+ T cells
[2,14,15]; whether the model is also applicable to CD4+
cells is less clear.
Antigen presentation in vivo
A corollary of the above model is that, under the
conditions encountered in vivo, a very wide variety of
different cell types have the potential to present antigen to
unprimed CD8+ cells. In the absence of exogenous help
from cytokines, however, one would expect antigen-
presenting function leading to overt T-cell stimulation to
be limited to professional antigen-presenting cells. But this
may apply only to the majority population of T cells that
have 'average' affinity for antigen. In the case of high-
affinity T cells, it is conceivable that contact with antigen
on various nonprofessional antigen-presenting cells is suf-
ficient to activate the T cells and stimulate endogenous IL-
2 production, thereby bypassing the requirement for
exogenous IL-2. In support of this idea, it has been found
that exposing naive CD8+ cells to class I alloantigens
expressed selectively on non-bone-marrow-derived cells
in bone marrow chimeras activates a small proportion of
the CD8+ cells to proliferate and differentiate into CTL
in the absence of CD4+ cells [16]. Likewise, injecting
purified naive CD8+ cells subcutaneously into heavily
irradiated syngeneic mice together with allogeneic
(MHC-incompatible) tumor cells leads to rapid destruc-
tion of the tumor cells: these cells initially act as direct
antigen-presenting cells for the CD8+ cells and then
become targets for the CTL they induce [17]. Further evi-
dence that professional antigen-presenting cells are not
essential for T-cell responses in vivo is provided by the
recent finding that mice that display a selective depletion
of dendritic cells - through disruption of the relB gene
Fig. 1. The functional differences
between professional and non-profes-
sional antigen-presenting cells. See text
for further details.
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- are capable of mounting low but significant antibody
responses to T-cell-dependent antigens [18].
As argued above, stimulation of unprimed T cells in vivo by
nonprofessional antigen-presenting cells is likely to be lim-
ited to a small subset of high-affinity T cells. In the experi-
ments of Kundig et al. [7] mentioned earlier, mice were
injected with a syngeneic, MHC class I-positive fibrosar-
coma cell line transfected with the glycoprotein of lym-
phocytic choriomeningitis virus. When tested in vitro, the
transfected cells failed to stimulate glycoprotein-specific T
cells unless supplemented with exogenous IL-2. However,
despite lacking several key costimulatory molecules (B7,
ICAM-1, LFA-1), the transfected cells elicited quite strong
induction of CTL in vivo, especially after direct intrasplenic
injection. Various control experiments suggested that the
injected cells acted as direct antigen-presenting cells and
did not require 'processing' by host cells; 'help' from
CD4+ cells was not required because prior elimination of
CD4+ cells did not inhibit the response.
In light of these findings, the authors argue that non-
professional antigen-presenting cells such as fibroblasts can
act as a significant source of antigen presentation in vivo
(but only if the nonprofessional cells reach the central lym-
phoid tissues). To explain the discrepancy with the data in
vitro, the authors argue that antigen presentation by fibrob-
lasts in vivo depends upon help from "the abundance of co-
stimulatory cytokines in lymphoid organs...". The problem
with this interpretation is that there is little if any direct
evidence that the background level of IL-2 in normal lym-
phoid organs is sufficient to provide such bystander help.
Three other possibilities may be considered. First, it is
conceivable that the antigen-presenting function of fibrob-
lasts in vivo reflects enhanced expression of MHC class I
molecules [2] and/or up-regulation of costimulatory mol-
ecules. Second, adjacent host antigen-presenting cells
could provide bystander costimulatory function for the
responding T cells [4]. Third, harking back to the model
considered earlier, the transfected fibroblasts may have
been directly immunogenic for a small subset of high-
affinity T cells which then underwent prolonged expan-
sion followed by differentiation into CTL. This possibility
could be assessed by testing the affinity of the CTL gener-
ated, for example by examining the susceptibility of the
cells to inhibition with anti-CD8 antibody.
Whatever the explanation, the data of Kundig et al. [7]
reinforce the view that stimulation of unprimed T cells in
vivo is not necessarily limited to professional antigen-
presenting cells. As emphasized by these workers, how-
ever, it is highly likely that primary immune responses are
restricted to the primary lymphoid organs - the spleen
and the draining lymph nodes, in the case of viral infec-
tions. In these organs, the range of cell types available for
antigen-presenting function is quite small. Indeed, in the
T-cell-dependent areas, dendritic cells are virtually the
only cell type present (except or T cells themselves and a
few resting B cells). Hence, naive resting T cells entering
the lymphoid organs from the recirculating lymphocyte
pool will encounter antigen largely, and perhaps
exclusively, presented by dendritic cells, the quintessential
professional antigen-presenting cells. Under normal physi-
ological conditions, therefore, it is highly likely that initial
antigen presentation is by dendritic cells. After their initial
activation by dendritic cells, however, it is quite possible
that activated T cells then move to adjacent areas of the
lymphoid tissues, such as the red pulp of the spleen, and
there receive subsidiary antigen presentation from other
cells such as macrophages, activated B cells and stromal
cells such as fibroblasts. This secondary contact with non-
professional antigen-presenting cells could be crucial for
expanding the responding T cell clones and inducing dif-
ferentiation into effector cells.
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